These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20831548)

  • 21. Association between genetic polymorphisms of cytochrome P450 2C19 and the risk of cerebral ischemic stroke in Chinese.
    Gu S; Sun Y; Han R; Wang L; Wang D; Wang J; Li X
    BMC Med Genet; 2014 Jul; 15():83. PubMed ID: 25030528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype.
    Herrlin K; Massele AY; Jande M; Alm C; Tybring G; Abdi YA; Wennerholm A; Johansson I; Dahl ML; Bertilsson L; Gustafsson LL
    Clin Pharmacol Ther; 1998 Oct; 64(4):391-401. PubMed ID: 9797796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (‑806 C>T) alleles among an Iranian population of different ethnicities.
    Dehbozorgi M; Kamalidehghan B; Hosseini I; Dehghanfard Z; Sangtarash MH; Firoozi M; Ahmadipour F; Meng GY; Houshmand M
    Mol Med Rep; 2018 Mar; 17(3):4195-4202. PubMed ID: 29328413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study.
    Dodgen TM; Hochfeld WE; Fickl H; Asfaha SM; Durandt C; Rheeder P; Drögemöller BI; Wright GE; Warnich L; Labuschagne CD; van Schalkwyk A; Gaedigk A; Pepper MS
    BMC Med Genet; 2013 Jan; 14():20. PubMed ID: 23356658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.
    Ragia G; Arvanitidis KI; Tavridou A; Manolopoulos VG
    Pharmacogenomics; 2009 Jan; 10(1):43-9. PubMed ID: 19102714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.
    Tassaneeyakul W; Tawalee A; Tassaneeyakul W; Kukongviriyapan V; Blaisdell J; Goldstein JA; Gaysornsiri D
    Pharmacogenetics; 2002 Apr; 12(3):221-5. PubMed ID: 11927837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.
    Wang JH; Li PQ; Fu QY; Li QX; Cai WW
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):421-4. PubMed ID: 17439410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.
    Subraja K; Dkhar SA; Priyadharsini R; Ravindra BK; Shewade DG; Satheesh S; Sridhar MG; Narayan SK; Adithan C
    Eur J Clin Pharmacol; 2013 Mar; 69(3):415-22. PubMed ID: 22955794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
    Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
    Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressing Preemptive Genotyping of CYP2C19 Allelic Variants for Sickle Cell Disease Patients.
    Jaja C; Barrett N; Patel N; Lyon M; Xu H; Kutlar A
    Genet Test Mol Biomarkers; 2016 Oct; 20(10):609-615. PubMed ID: 27551817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population.
    Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J
    Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.
    Yang ZF; Cui HW; Hasi T; Jia SQ; Gong ML; Su XL
    Genet Mol Res; 2010 Sep; 9(3):1844-51. PubMed ID: 20845310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations.
    Tassaneeyakul W; Mahatthanatrakul W; Niwatananun K; Na-Bangchang K; Tawalee A; Krikreangsak N; Cykleng U; Tassaneeyakul W
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):286-90. PubMed ID: 16946555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations.
    Lee SS; Lee SJ; Gwak J; Jung HJ; Thi-Le H; Song IS; Kim EY; Shin JG
    Ther Drug Monit; 2007 Aug; 29(4):455-9. PubMed ID: 17667801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.
    Allabi AC; Gala JL; Desager JP; Heusterspreute M; Horsmans Y
    Br J Clin Pharmacol; 2003 Dec; 56(6):653-7. PubMed ID: 14616425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
    Hashemi-Soteh SM; Shahabi-Majd N; Gholizadeh AR; Shiran MR
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.
    Ellison CA; Abou El-Ella SS; Tawfik M; Lein PJ; Olson JR
    J Toxicol Environ Health A; 2012; 75(4):232-41. PubMed ID: 22352331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of CYP2C19 polymorphisms in the Lebanese population.
    Djaffar Jureidini I; Chamseddine N; Keleshian S; Naoufal R; Zahed L; Hakime N
    Mol Biol Rep; 2011 Nov; 38(8):5449-52. PubMed ID: 21380557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.